3 results
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
/ g-KWest.
This study enrolled a total of 10 adults (five men and five women) with CKD resulting from type 2 DKD (kidney function measured by eGFR
POS AM
PROK
ProKidney Corp - Ordinary Shares
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
/1.73m2. Subjects receive up to two doses of REACT of 3x106 cells/ g-KWest.
This study enrolled a total of 10 adults (five men and five women
- Prev
- 1
- Next